157 related articles for article (PubMed ID: 38711262)
1. MEIS2 suppresses breast cancer development by downregulating IL10.
Xiao Y; Liu Y; Sun Y; Huang C; Zhong S
Cancer Rep (Hoboken); 2024 May; 7(5):e2064. PubMed ID: 38711262
[TBL] [Abstract][Full Text] [Related]
2. LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p.
Li D; Hu A
Am J Med Sci; 2024 Mar; 367(3):201-211. PubMed ID: 37660994
[TBL] [Abstract][Full Text] [Related]
3. The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors.
Abruzzese MP; Bilotta MT; Fionda C; Zingoni A; Soriani A; Petrucci MT; Ricciardi MR; Molfetta R; Paolini R; Santoni A; Cippitelli M
Cell Death Dis; 2019 Apr; 10(4):324. PubMed ID: 30975979
[TBL] [Abstract][Full Text] [Related]
4. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
5. MEIS2 promotes cell migration and invasion in colorectal cancer.
Wan Z; Chai R; Yuan H; Chen B; Dong Q; Zheng B; Mou X; Pan W; Tu Y; Yang Q; Tu S; Hu X
Oncol Rep; 2019 Jul; 42(1):213-223. PubMed ID: 31115559
[TBL] [Abstract][Full Text] [Related]
6. Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway.
Wen X; Liu M; Du J; Wang X
Bioengineered; 2021 Dec; 12(1):1766-1772. PubMed ID: 33975520
[TBL] [Abstract][Full Text] [Related]
7. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
[No Abstract] [Full Text] [Related]
9. Epigenetic silencing of MEIS2 in prostate cancer recurrence.
Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD
Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
13. Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway.
Shen J; Wang M; Li F; Yan H; Zhou J
Bioengineered; 2022 Jan; 13(1):1335-1345. PubMed ID: 34983296
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2.
Zhang Y; Lin W; Jiang W; Wang Z
Bioengineered; 2022 Apr; 13(4):9959-9972. PubMed ID: 35416122
[TBL] [Abstract][Full Text] [Related]
16. ERN1 dependent impact of glucose and glutamine deprivations on PBX3, PBXIP1, PAX6, MEIS1, and MEIS2 genes expression in U87 glioma cells.
Krasnytska DO; Viletska YM; Minchenko DO; Khita OO; Tsymbal DO; Cherednychenko AA; Kozynkevych HE; Oksiom NS; Minchenko OH
Endocr Regul; 2023 Jan; 57(1):37-47. PubMed ID: 36753664
[No Abstract] [Full Text] [Related]
17. MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression.
Zha Y; Xia Y; Ding J; Choi JH; Yang L; Dong Z; Yan C; Huang S; Ding HF
Cell Death Dis; 2014 Sep; 5(9):e1417. PubMed ID: 25210800
[TBL] [Abstract][Full Text] [Related]
18. Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2.
Han D; Li X; Cheng Y
Chem Res Toxicol; 2023 Mar; 36(3):360-368. PubMed ID: 36763086
[TBL] [Abstract][Full Text] [Related]
19. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
20. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
